Otavia L. Caballero

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant.

Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant.

Journal: Vaccine
Published: December 05, 2023

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease.

ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease.

Journal: NPJ vaccines
Published: June 07, 2022

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.

Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.

Journal: Nature communications
Published: April 15, 2022

Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.

Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events.

Journal: Cancers
Published: March 09, 2021

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy.

The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy.

Journal: Oncotarget
Published: December 08, 2020

P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring.

P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring.

Journal: Oncoscience
Published: August 23, 2017

NY-ESO-1 expression in DCIS: A new predictor of good prognosis.

NY-ESO-1 expression in DCIS: A new predictor of good prognosis.

Journal: Oncoscience
Published: January 18, 2017

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP.

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP.

Journal: Cancer cell
Published: November 16, 2016

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro.

Journal: Stem cell reviews and reports
Published: October 31, 2015

Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.

Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial-Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity.

Journal: Cancer immunology research
Published: October 14, 2015

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.

Journal: Oncoscience
Published: June 16, 2015

NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.

NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.

Journal: Cancer immunology research
Published: April 30, 2014
Showing 1-12 of 32

Last Updated: 09/26/2026